Company Profile



San Francisco, California, USA

Founded Year




Operating Status


Social Media


John Axerio-Cilies

Albert Hsiao, MD, PhD

Shreyas Vasanawala

Fabien Beckers


Arterys is a cutting-edge medical imaging company that utilizes artificial intelligence and cloud-based technology to provide highly accurate and efficient diagnostic tools for healthcare providers.

With a focus on advancing healthcare through innovation, Arterys has established itself as a leading provider of medical imaging solutions that improve patient outcomes.

Founded in 2012, Arterys has quickly become a prominent player in the medical technology industry, with a mission to revolutionize the way medical imaging is performed.

By combining state-of-the-art technology with a team of highly skilled medical experts, Arterys has developed a range of groundbreaking products that enable doctors and researchers to analyze medical images with unparalleled precision and speed.

Arterys' products include its flagship Cardio AI software, which uses machine learning algorithms to analyze cardiac MRI scans and provide clinicians with detailed insights into a patient's heart health.

The company also offers Liver AI, which enables doctors to quickly and accurately diagnose liver disease, as well as Lung AI, which provides detailed analysis of lung nodules and other abnormalities.

With a team of more than 50 employees and offices in San Francisco, Madrid, and Pune, Arterys is a rapidly growing company that is poised to make a significant impact in the medical technology industry.

The company has received numerous awards and accolades for its innovative products and commitment to improving patient care, and has attracted significant investment from some of the world's leading venture capital firms.

Overall, Arterys is a dynamic and forward-thinking company that is dedicated to using technology to improve healthcare outcomes. With a focus on innovation, accuracy, and efficiency, Arterys is at the forefront of a new era of medical imaging


Neuro AI - Stroke notification

The Neuro AI platform offers a comprehensive set of AI-powered neuroimaging applications that are clinically valuable and independent of any particular vendor.

These tools are designed to automatically generate customizable reports that are easy for physicians to interpret, enabling them to make swift and precise diagnostic and treatment choices for patients with conditions such as stroke, neurodegenerative disease, multiple sclerosis, and brain tumors.

Utilizing AI-based segmentation, the Neuro AI platform solution for neurodegenerative disease offers a precise and consistent quantitative assessment of T1-weighted MRI brain scans.

This innovative solution provides an automated report that enables users to track changes over time, providing measurements that were previously unattainable within the time constraints of clinical workflows using manual approaches.

Similar Companies

About Us

futureTEKnow is a global database of emerging technology companies. Discover the latest disruptors and innovators in the field.



Trending Today